Researchers explore conflicts of interest in cardiovsacular care guidelines

Mar 29, 2011

A new analysis by researchers at the University of Pennsylvania School of Medicine of recent cardiology clinical practice guidelines has found that more than half of the experts involved in the development of these guidelines reported a conflict of interest (COI).

“The extent of COIs in cardiology guideline production had not been well studied up to this point. Our findings that most episodes of guidelines participation involve COIs, and that most individuals involved in producing guidelines report COIs, is a cause for concern,” said corresponding author James N. Kirkpatrick, MD, assistant professor of Medicine and colleagues at Penn. “However, the results of this study also highlight that a strong pool of experts without any COIs are available to direct the clinical practice guideline development process.”

For the analysis, the examined 17 different cardiology guidelines through 2008. Using disclosure lists from the actual guidelines, the researchers cataloged COIs for each participant as receiving a research grant, being on a speaker's bureau and/or receiving honoraria, owning stock, or being a consultant or member of an advisory board. The researchers also cataloged the companies and institutions reported in each disclosure. "Episode" describes one instance of participation in one guideline by one person. "Individual" describes one person who may be involved in multiple episodes.

In the 17 , the researchers found 651 episodes of participation by 498 individuals. A total of 277 of the 498 individuals (56 percent) reported a COI. On average, each individual participated in 1.31 episodes. Over half of the episodes (365 of 651 [56 percent]) involved a COI. The most common form of COI was consultant/advisory board, followed by research grant, honoraria/speakers' bureau, and stock/other ownership.

Explore further: FTC clears Sun Pharma's $4B purchase of competitor Ranbaxy

More information: The analysis results are reported in the March 28 issue of Archives of Internal Medicine. For more information, please see the Archives of Internal Medicine press release: pubs.ama-assn.org/homepage/media/2011a/0328.dtl#3

add to favorites email to friend print save as pdf

Related Stories

Developing guidelines for better reporting of health research

Feb 16, 2010

A paper published in this week's issue of PLoS Medicine provides a substantial new resource for the developers of guidelines of the reporting of health research. The authors of the paper have been key in the development of man ...

Reviewers agree on osteoarthritis of the knee

Dec 06, 2007

Concerns over the cardiovascular safety of non-steroidal anti-inflammatory drugs (NSAIDs) led to the publication of several sets of fresh guidelines on the treatment of knee osteoarthritis. But a review of these guidelines, ...

Not all doctors follow cancer screening guidelines

Oct 14, 2010

Only one-fifth of primary care physicians in the US follow practice guidelines for colorectal cancer screening for all the tests they recommend, according to Dr. Robin Yabroff from the National Cancer Institute and her colleagues. ...

Recommended for you

Why aren't there any human doctors in Star Wars?

Jan 30, 2015

Though set "a long time ago in a galaxy far, far away," it isn't hard to see in the Star Wars films a vision of our own not so distant future. But Anthony Jones, a physician with a long background in health ...

Cambodia bans 'virgin surgery' adverts

Jan 29, 2015

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.